1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with epalrestat in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (epalrestat) | Trials (epalrestat) | Recent Studies (post-2010) (epalrestat) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 243 | 22 | 100 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | epalrestat (IC50) |
---|---|---|---|
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 7.9635 | |
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 6.5 | |
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 0.1836 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.5596 | |
Aldo-keto reductase family 1 member A1 | Homo sapiens (human) | 2.6 | |
Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 0.1335 | |
Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | 0.17 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.085 | |
Aldo-keto reductase family 1 member A1 | Sus scrofa (pig) | 1.5 | |
Aldo-keto reductase family 1 member A1 | Rattus norvegicus (Norway rat) | 1.5 | |
Aldo-keto reductase family 1 member B7 | Rattus norvegicus (Norway rat) | 1.198 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anami, Y; Higashi, T; Kasho, M; Kobori, S; Nishikawa, T; Sato, Y; Shichiri, M; Takeda, H; Yano, T | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and epalrestat
Article | Year |
---|---|
Release of fructose and hexose phosphates from perivascular cells induced by low density lipoprotein and acceleration of protein glycation in vitro.
Topics: Aldehyde Reductase; Animals; Aorta, Thoracic; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Fructose; Glycoproteins; Glycosylation; Hexosephosphates; Humans; Kinetics; L-Lactate Dehydrogenase; Lipoproteins, LDL; Muscle, Smooth, Vascular; Oxidation-Reduction; Oxidative Stress; Platelet Activating Factor; Probucol; Rabbits; Rhodanine; Thiazolidines; Thiobarbituric Acid Reactive Substances; Umbilical Veins | 1996 |